Drug Interactions between Colcrys and lisinopril
This report displays the potential drug interactions for the following 2 drugs:
- Colcrys (colchicine)
Interactions between your drugs
No interactions were found between Colcrys and lisinopril. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Colcrys is in the drug class antigout agents.
- Colcrys is used to treat the following conditions:
- Lisinopril is in the drug class Angiotensin Converting Enzyme Inhibitors.
- Lisinopril is used to treat the following conditions:
Drug and food interactions
Applies to: Colcrys (colchicine)
Drinking large amounts of grapefruit juice can increase your blood levels of colchicine to dangerous levels. You should avoid the consumption of grapefruit or grapefruit juice during treatment with colchicine. Let your doctor know if you experience abdominal pain, nausea, vomiting, diarrhea, fever, muscle pain, weakness, fatigue, and/or numbness or tingling in your hands and feet, as these may be early symptoms of colchicine toxicity.
Applies to: lisinopril
It is recommended that if you are taking lisinopril you should be advised to avoid moderately high or high potassium dietary intake. This can cause high levels of potassium in your blood. Do not use salt substitutes or potassium supplements while taking lisinopril, unless your doctor has told you to.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|